Humalog Mix25 improves 24-hour plasma glucose profiles compared with the human insulin mixture 30/70 in patients with type 2 diabetes mellitus

South African Medical Journal

Volumn 93, Issue 3, 2003, Pages 219-223

  Herz, M ^a   Arora, V ^d   Campaigne, B N ^d   Scholtz, H E ^b   Potgieter, M A ^b   Mollentze, W ^c  

^a Lilly Deutchland GMbH   (Germany)

^b FARMOVS Research Centre   (South Africa)

^c UNIVERSITY OF THE FREE STATE   (South Africa)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOSE; HEMOGLOBIN A1C; HUMALOG MIX25; HUMAN INSULIN; INSULIN LISPRO; ORAL ANTIDIABETIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ACTIVITY; DRUG DOSE REGIMEN; DRUG MIXTURE; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; MALE; MEAL; NIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; OUTPATIENT; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PILOT PROJECTS; TIME FACTORS;

EID: 0037368873     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bell DSH, Clements RS, Perentesis G, Roddam R, Wagenknecht L. Dosage accuracy of self-mixed vs. premixed insulin. Arch Intern Med J 1991; 151: 2265-2269.
2. Dimitriadis GD, Gerich JE. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 1983; 6: 374-377.
3. Janssen MMJ, Casteleijn S, Deville W, Popp-Snijders C, Roach P, Heine RJ. Nighttime insulin kinetics and glycemic control in type 1 diabetes patients following administration of an intermediate-acting lispo preparation. Diabetes Care 1997; 20: 1870-1873.
4. Roach P, Yue L, Arora V, The Humalog Mix25 Study Group. Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation. Diabetes Care 1999; 22: 1258-1261.
5. Roach P, Trautmann M, Arora V, Sun B, Anderson JH jun. Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, Insulin Lispro Mix25 and Insulin Lispro Mix50. Clin Ther 1999; 21: 523-534.
6. Koivisto VA, Tuominen JA, Ebeling P. Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients. Diabetes Care 1999; 22: 459-462.
7. Malone JK, Woodworth JR, Arora V, et al. Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus. Clin Ther 2000; 22: 222-230.
8. The World Health Organisation Classification of Diabetes. In: Pickup JC, Williams G, eds. Textbook of Diabetes. Vol. 1. Oxford: Blackwell Scientific Publications, 1991: 39.
9. Koch GG. The use of non-parametric methods in statistical analysis of the two period change-over design. Biometrics 1972; 28: 577-584.
10. Taulbee JD. A note on the use of nonparametric methods in the statistical analysis of the two-period changeover design. Biometrics 1982; 38: 1053-1055.
11. Rodriguez BL, Lau N, Burchfiel CM, et al. Glucose intolerance and 23-year risk of coronary heart disease and total mortality. Diabetes Care 1999; 22: 1262-1265.
12. Hanefield M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study. 11-year follow-up. Diabetologia 1996; 39: 1577-1583.
13. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diab Res Clin Pract 1995; 28: 103-117.
14. Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995; 44: 968-983.
15. Lean MEJ, Ng LL, Tennison BR. Interval between insulin injection and eating in relation to blood glucose control in adult diabetes. BMJ 1985; 290: 105-108.